Skip to main content
SpringerLink
Log in

Businessplan für die MS-Forschung

Brücke zwischen Uni und Industrie

  • Medizin aktuell
  • Published:
DNP - Der Neurologe und Psychiater Aims and scope

Grundlagenforscher und klinische Wissenschaftler leben in verschiedenen Welten. Zwei Stiftungen wollen dies ändern und damit die Entwicklung von neuen MS-Medikamenten beschleunigen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. http://www.springermedizin.de

    Thomas Müller

Authors
  1. Thomas Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Müller, T. Businessplan für die MS-Forschung. DNP 15, 22 (2014). https://doi.org/10.1007/s15202-014-0956-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15202-014-0956-x

Search

Navigation